ÂÜŔňÂŇÂ×

Dr. Eifrig has one of the most remarkable resumes of anyone we know in this industry. After receiving his BA from the Carleton College in Minnesota, he went on to earn an MBA from Northwestern University’s Kellogg School of Management, graduating on the Dean’s List with a double major in finance and international business.

From there, Dr. Eifrig went to work as an elite derivatives trader at the investment bank Goldman Sachs. He spent a decade on Wall Street with several major institutions, including Chase Manhattan and Yamaichi (then known as the “Goldman Sachs of Japan”).

That’s when Dr. Eifrig’s career took an unconventional turn. Sick of the greed and hypocrisy of Wall Street... he quit his senior vice president position to become a doctor. He graduated from Columbia University’s post-baccalaureate pre-medicine program and eventually earned his MD with clinical honors from the University of North Carolina at Chapel Hill. While at med school, he was elected president of his class and admitted to the Order of the Golden Fleece (considered the highest honor given at UNC-Chapel Hill).

Dr. Eifrig also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotech company, Mirus, that was sold to Roche for $125 million in 2008.